Skip to main content
. 2018 Jun 26;17:1533033818782793. doi: 10.1177/1533033818782793

Table 3.

Results of TNF-α Promoter Gene SNP Genotype by Group.a

Group N rs361525 (N) χ2/P b rs1800629 (N) χ2/P b rs1800750 (N) χ2/P b rs1799964 (N) χ2/P b rs673 (N) χ2/P b
CC CT TT GG AG AA GG AG AA GG AG AA GG AG AA
Control 494 475 19 0 424 70 0 492 2 0 410 81 3 483 11 0
Cervical squamous cell carcinoma 452 403 49 0 χ2 = 20.707 317 135 0 χ2 = 34.916 450 2 0 χ2 = 2.539 275 173 4 χ2 = 57.396 440 12 0 χ2 = 0.212
  Carcinoma In situ 104 97 7 0 P < .001 76 28 0 P < .001 104 0 0 P = .281 67 37 1 P < .001 101 3 0 P = .899
  Invasive carcinoma 348 306 42 0 241 107 0 344 4 0 212 136 3 339 9 0

Abbreviations: TNF-α, tumor necrosis factor-α; SNP, single nucleotide polymorphisms.

a C-cytosine; T-thymidine; A-adenine, and G-guanine. The base pair of rs361525 gene is C and T, where CC and TT being homozygous and CT being heterozygous; the base pair for other 4 SNP sites were all G, A, GG, and AA being homozygous, and AG being heterozygous.

b Used the Cochran-Mantel-Haenszel (CMH) test.